×

2017 Diagnostic Cytopathology



Evaluated by: David B. Kaminsky, M.D., FIAC, August 15, 2017
Original release date: August 15, 2017
Last day to purchase course and claim credit: January 14, 2020
CME/SAMs 12.5

Course Director: Ritu Nayar, MBBS, M.D.

USCAP’s Diagnostic Cytopathology 2017 features five of the lead authors of the most relevant and recent guidelines in diagnostic cytopathology today:
  • Dr. Edmund Cibas for The Bethesda System for Reporting Thyroid Cytology 
  • Dr. Ritu Nayar for The Bethesda System for Reporting Cervical Cytology 
  • Dr. William Faquin for the Milan System for Reporting Salivary Gland Cytology 
  • Dr. Martha Bishop Pitman for The Papanicolaou Society of Cytopathology System for Reporting Pancreaticobiliary Cytology 
  • Dr. Eva Wojcik for The Paris System for Reporting Urinary Cytology 
  • Dr. Sara E. Monaco will address another hot topic, EBUS and molecular testing in lung cancer  
Cytopathologist experts provide insights and expertise to help build your working knowledge for diagnostic cytopathology. Images and molecular testing are presented in a clear and concise fashion.

Patient care is optimized when cytopathologists communicate their diagnostic findings effectively to clinicians and intelligibly to patients. A systematic reporting system that includes guidelines is an effective approach to this objective and represents a valiant effort to transfer valid information with clarity. Collaborative academic institutions have addressed reporting systems and guidelines for the uterine cervix, thyroid, salivary glands, pancreaticobiliary system and urine cytology.

Interwoven is information that will address professional practice gaps in current cytopathology procedures, adjunctive and molecular/genetic techniques and focus issues that will enhance community and academic practices.

The United States and Canadian Academy of Pathology is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

The United States and Canadian Academy of Pathology designates this enduring material for a maximum of 12.5 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity. 

The USCAP is approved by the American Board of Pathology (ABP) to offer Self-Assessment credits (SAMs) for the purpose of meeting the ABP requirements for Maintenance of Certification (MOC). Registrants must take and pass the post-test in order to claim SAMs credit.

Physicians can earn a maximum of 12.5 SAM credit hours.

The faculty, committee members, and staff who are in position to control the content of this activity are required to disclose to USCAP and to learners any relevant financial relationship(s) of the individual or spouse/partner that have occurred within the last 12 months with any commercial interest(s) whose products or services are related to the CME content. USCAP has reviewed all disclosures and resolved or managed all identified conflicts of interest, as applicable.

The following faculty reported no relevant financial relationships: Edmund S. Cibas, M.D., Ritu Nayar, MBBS, M.D., William Faquin, M.D., Ph.D., Martha Bishop Pitman, M.D., Eva Wojcik, M.D., and Sara E. Monaco, M.D. 

USCAP staff associated with the development of content for this activity reported no relevant financial relationships.
To earn CME and SAM credit, all learners must take a content-based exam and achieve a minimum score of 80%. If learners do not achieve a passing score of 80%, they have the option to retake the exam. After you pass the test and complete the evaluation, your certificate of completion will be available to view and print by clicking here.

Purchase the whole course and save! If you are not a member and would like to enjoy member pricing you can apply for membership by clicking here.